Beyond ALK and EGFR: Novel Molecularly Driven Targeted Therapies in NSCLC

Date 04 April 2018
Event ESMO-The Christie Preceptorship on Lung Cancer Manchester March 2018
Session Session 3 Advanced NSCLC cont.
Topics Non-Small-Cell Lung Cancer, Metastatic
Personalised Medicine
Presenter S. Ekman, SE